Sljedeći

Auto Play

Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms

2 Pogledi • 07/29/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play